Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “RUTHENIUM 106”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 records

{sup 106}Ruthenium Plaque Therapy (RPT) for Retinoblastoma

Purpose: To evaluate the effectiveness of episcleral {sup 106}ruthenium plaque therapy (RPT) in the management of retinoblastoma. Methods and Materials: One hundred one RPTs were retrospectively analyzed that were performed in 90 eyes of 85 patients with retinoblastoma at National Cancer Center Hospital between 1998 and 2008. Each RPT had a corresponding tumor and 101 tumors were considered in the analysis of local control. Median follow-up length was 72.8 months. Median patient age at the RPT was 28 months. Median prescribed doses at reference depth and outer surface of the sclera were 47.4 Gy and 162.3 Gy, respectively. Results: Local control rate (LCR) and ocular retention rate (ORR) at 2 years were 33.7% and 58.7%, respectively. Unilateral disease, International Classification of Retinoblastoma group C or more advanced at the first presentation or at the time of RPT, vitreous and/or subretinal seeding, tumor size greater than 5 disc diameter (DD), reference depth greater than 5 mm, dose rate at reference depth lower than 0.7 Gy/hour, dose at the reference depth lower than 35 Gy, and (biologically effective dose with an {alpha}/{beta} ratio of 10 Gy) at the reference depth lower than 40 Gy{sub 10} were associated with unfavorable LCR. Two patients died of metastatic disease. Radiation complications included retinal detachment in 12 eyes (13.3%), proliferative retinopathy in 6 (6.7%), rubeosis iris in 2 (2.2%), and posterior subcapsular cataract in 23 (25.6%). Conclusion: RPT is an effective eye-preserving treatment for retinoblastoma.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

{sup 106}Ruthenium Brachytherapy for Retinoblastoma

Purpose: To evaluate the efficacy of {sup 106}Ru plaque brachytherapy for the treatment of retinoblastoma. Methods and Materials: We reviewed a retrospective, noncomparative case series of 39 children with retinoblastoma treated with {sup 106}Ru plaques at the Jules-Gonin Eye Hospital between October 1992 and July 2006, with 12 months of follow-up. Results: A total of 63 tumors were treated with {sup 106}Ru brachytherapy in 41 eyes. The median patient age was 27 months. {sup 106}Ru brachytherapy was the first-line treatment for 3 tumors (4.8%), second-line treatment for 13 (20.6%), and salvage treatment for 47 tumors (74.6%) resistant to other treatment modalities. Overall tumor control was achieved in 73% at 1 year. Tumor recurrence at 12 months was observed in 2 (12.5%) of 16 tumors for which {sup 106}Ru brachytherapy was used as the first- or second-line treatment and in 15 (31.9%) of 47 tumors for which {sup 106}Ru brachytherapy was used as salvage treatment. Eye retention was achieved in 76% of cases (31 of 41 eyes). Univariate and multivariate analyses revealed no statistically significant risk factors for tumor recurrence. Radiation complications included retinal detachment in 7 (17.1%), proliferative retinopathy in 1 (2.4%), and subcapsular cataract in 4 (9.7%) of 41 eyes. Conclusion: {sup 106}Ru brachytherapy is an effective treatment for retinoblastoma, with few secondary complications. Local vitreous seeding can be successfully treated with {sup 106}Ru brachytherapy.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Local Tumor Control, Visual Acuity, and Survival After Hypofractionated Stereotactic Photon Radiotherapy of Choroidal Melanoma in 212 Patients Treated Between 1997 and 2007

Purpose: To evaluate long-term local tumor control, visual acuity, and survival after hypofractionated linear accelerator-based stereotactic photon radiotherapy in patients with choroidal melanoma. Methods and Materials: Between 1997 and 2007, 212 patients with choroidal melanoma unsuitable for ruthenium-106 brachytherapy or local resection were treated stereotactically at a linear accelerator with 6-MV photon beams at the Medical University of Vienna in five fractions over 7 days. Twenty-four patients received a total dose of 70 Gy (five fractions of 14 Gy), 158 a total dose of 60 Gy (five fractions of 12 Gy) and 30 patients a total dose of 50 Gy (five fractions of 10 Gy) applied on the 80% isodose. Ophthalmologic examinations were performed at baseline and every 3 months in the first 2 years, every 6 months until 5 years, and once a year thereafter until 10 years after radiotherapy. Assessment of visual acuity, routine ophthalmologic examinations, and measurement of tumor base dimension and height using standardized A-scan and B-scan echography were done at each visit. Funduscopy and fluorescein angiography were done when necessary to document tumor response. Results: Median tumor height and volume decreased from 4.8 mm and 270.7 mm{sup 3} at baseline to 2.6 mm and 86.6 mm{sup 3} at the last individual follow-up, respectively (p < 0.001, p < 0.001). Median visual acuity decreased from 0.55 at baseline to hand motion at the last individual follow-up (p < 0.001). Local tumor control was 95.9% after 5 years and 92.6% after 10 years. Thirty-two patients developed metastatic disease, and 22 of these patients died during the follow-up period. Conclusion: Hypofractionated stereotactic photon radiotherapy with 70 to 50 Gy delivered in five fractions in 7 days is sufficient to achieve excellent local tumor control in patients with malignant melanoma of the choroid. Disease outcome and vision are comparable to those achieved with proton beam radiotherapy. Decreasing the total dose below 60 Gy seems to be possible.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Nuclear Data Sheets for A = 106

The 1994 evaluation on mass A = 106 has been revised, taking into account all data available before May 2007. Detailed experimental information is presented from the neutron rich nucleus {sup 106}Y to the neutron deficient {sup 106}Te nucleus. All conversion coefficients have been calculated with BRICC.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Testing of New Technetium Selective Media TcTreat - 16497

A new zirconium oxide based material TcTreat is under development and testing for the removal of radioactive oxo-anionic species (Tc-99 pertechnetate, Ru-106 ruthenate) from solution. TcTreat exhibited a very high {sup 99}Tc uptake over a broad pH-range of 4-10 and the uptake was reasonably high also in mildly alkaline and acidic ranges. Nitrate and sulphate had a decreasing effect on {sup 99}Tc uptake but is was still strong (k{sub d} = 100,000 ml/g and above) even at 1 molar concentrations.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

The Easy Way of Finding Parameters in IBM (EWofFP-IBM)

E2/M1 multipole mixing ratios of even-even nuclei in transitional region can be calculated as soon as B(E2) and B(M1) values by using the PHINT and/or NP-BOS codes. The correct calculations of energies must be obtained to produce such calculations. Also, the correct parameter values are needed to calculate the energies. The logic of the codes is based on the mathematical and physical Statements describing interacting boson model (IBM) which is one of the model of nuclear structure physics. Here, the big problem is to find the best fitted parameters values of the model. So, by using the Easy Way of Finding Parameters in IBM (EWofFP-IBM), the best parameter values of IBM Hamiltonian for {sup 102-110}Pd and {sup 102-110}Ru isotopes were firstly obtained and then the energies were calculated. At the end, it was seen that the calculated results are in good agreement with the experimental ones. In addition, it was carried out that the presented energy values obtained by using the EWofFP-IBM are dominantly better than the previous theoretical data.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Initial Assessment of Ruthenium Removal Systems for Tritium Pretreatment Off-Gas

The processing of used nuclear fuel releases volatile and semivolatile radionuclides into the off-gas streams associated with the various processing steps. Ongoing efforts to develop methods to control the release of gaseous radionuclides to the environment have identified ruthenium (specifically 106 Ru) as one of the semivolatile nuclides requiring a high degree of abatement. The tritium pretreatment process will release a fraction of the ruthenium as volatile ruthenium tetroxide (RuO 4 ). Scoping tests were conducted to characterize the adsorption/deposition of RuO 4 from dry gas streams by two different substrates: steel wool and silica gel. A simple test system was assembled to produce RuO 4 through oxidation of powdered ruthenium metal, followed by a temperature-controlled sorption column. Tests were conducted with no sorbent present in the column to obtain baseline data on the evolution of RuO 4 and deposition of ruthenium on the internal surfaces of the column. Silica gel and steel wool were tested as adsorbent media. Gaseous effluent from the column was scrubbed with caustic solution to remove any remaining ruthenium. Ultraviolet/visible spectroscopy (UV/Vis) and inductively coupled plasma–mass spectroscopy analyses were used to measure the amount of ruthenium in the scrub solutions. The UV/Vis analysis proved to be problematic because of precipitation of ruthenates, ruthenium oxides, and hydrated ruthenium oxides that occurred over time. An effective stabilization agent that does not adversely affect the desired spectra needs to be identified if this method is to be used in the future. There were indications that oxidation of powdered ruthenium metal did not generate a stream with steady concentration of RuO 4 , so improved techniques are needed for follow-on experiments designed to infer deposition rate. Both steel wool and silica gel are able to decrease the effluent Ru concentration by a factor of 10–100 during the 5-hour tests conducted. These tests were conducted using a dilute RuO 4 -bearing dry gas stream and the short test duration did not result in sorbent saturation or in an estimation of Ru breakthrough time. RuO 4 desorbs from silica gel at room temperature. As interactions between RuO 4 and silica gel are not irreversible, it cannot function as a disposal media without pretreatment to reduce RuO 4 to a less mobile species. Silica gel may be useful as a RuO 4 sorbent or delay media in some applications. Based on visual observations, steel wool was an effective deposition substrate with no evidence of RuO 4 release. The deposition form should be identified and methods to assay the ruthenium content need to be developed.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Initial Series of Ruthenium Adsorption Optimization Studies

The processing of used nuclear fuel releases volatile and semivolatile radionuclides into the off-gas streams associated with the various processing steps. Ongoing efforts to develop methods to control the release of gaseous radionuclides to the environm ent have identified ruthenium (specifically 106 Ru) as one of the semivolatile nuclides requiring a high degree of abatement. The tritium pretreatment process will release a fraction of the ruthenium as volatile ruthenium tetroxide (RuO 4 ). Tests were conducted to examine the deposition phenomena and provide prelim inary information pertinent to an engineering design of a sorption bed to remove RuO 4 from a gas stream (e.g., approximate length of the mass transfer zone and the loading per unit mass of sorbent).

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Results with a micro-cavity plasma panel detector

During the three last years, a complete study of a radiation detector based on plasma panel technology (main component of plasma television display) has been completed using source, cosmic ray and beam. This studies showed a fast response (O(5 ns)), high spatial resolution detection of ionizing particle and minimum ionizing particles. It shows very promising results in term of pixel-to-pixel uniformity and time stability of both signal shapes and rates. The prototype has also demonstrated very low background over a wide range of applied high voltages, excellent pixel response isolation, time resolutions of a few nanoseconds, and efficiencies above 95% over a 100-volt range for beta particles emitted by a {sup 106}Ru radioactive source. A full report will be presented (authors)

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗

Evaluation of Ruthenium Capture Methods for Tritium Pretreatment Off-Gas Streams

In the reprocessing of used nuclear fuel, radioactive elements are released into various plant off-gas streams. While much research and development has focused on the abatement of the volatile nuclides 3 H, 14 C, 85 Kr, and 129 I, the potential release of semivolatile isotopes that could also report to the off-gas streams in a reprocessing facility has been examined. Ruthenium (as 106 Ru) has been identified as one of the semivolatile nuclides requiring the greatest degree of abatement prior to discharging the plant off-gas to the environment.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Multidimensional dosimetry of {sup 106}Ru eye plaques using EBT3 films and its impact on treatment planning

Purpose: The purpose of this study was to establish a method to perform multidimensional radiochromic film measurements of {sup 106}Ru plaques and to benchmark the resulting dose distributions against Monte Carlo simulations (MC), microdiamond, and diode measurements. Methods: Absolute dose rates and relative dose distributions in multiple planes were determined for three different plaque models (CCB, CCA, and COB), and three different plaques per model, using EBT3 films in an in-house developed polystyrene phantom and the MCNP6 MC code. Dose difference maps were generated to analyze interplaque variations for a specific type, and for comparing measurements against MC simulations. Furthermore, dose distributions were validated against values specified by the manufacturer (BEBIG) and microdiamond and diode measurements in a water scanning phantom. Radial profiles were assessed and used to estimate dosimetric margins for a given combination of representative tumor geometry and plaque size. Results: Absolute dose rates at a reference depth of 2 mm on the central axis of the plaque show an agreement better than 5% (10%) when comparing film measurements (MCNP6) to the manufacturer’s data. The reproducibility of depth-dose profile measurements was <7% (2 SD) for all investigated detectors and plaque types. Dose difference maps revealed minor interplaque deviations for a specific plaque type due to inhomogeneities of the active layer. The evaluation of dosimetric margins showed that for a majority of the investigated cases, the tumor was not completely covered by the 100% isodose prescribed to the tumor apex if the difference between geometrical plaque size and tumor base ≤4 mm. Conclusions: EBT3 film dosimetry in an in-house developed phantom was successfully used to characterize the dosimetric properties of different {sup 106}Ru plaque models. The film measurements were validated against MC calculations and other experimental methods and showed a good agreement with data from BEBIG well within published tolerances. The dosimetric information as well as interplaque comparison can be used for comprehensive quality assurance and for considerations in the treatment planning of ophthalmic brachytherapy.

60 APPLIED LIFE SCIENCES↗

Comparison and investigation of production of specific nuclides by different fission yield data

Generally, passive gamma spectroscopy (PGS) is known as a useful technique for nondestructive measurement of burnup and nuclide production in normal spent nuclear fuel. However, PGS can be used not only for normal spent fuel, but also for molten fuel generated in severe accidents involving core meltdowns. In such cases, it is estimated by the radioactivity ratios of specific nuclides. At the time of the decommissioning of the Three Mile Island's unit 2 reactor, fission products (FPs) such as Cs{sup 134}, Cs{sup 137}, Ce{sup 144}, Eu{sup 154}, Ru{sup 106}, and Sb{sup 125} were concerned. The radioactivity ratios are estimated by numerical simulations. However, there are various uncertainties in numerical simulations. In this study, we evaluated the effect of the difference in fission yield data. We compared the productions of concerned nuclides of Three Mile Island's unit 2 reactor by using Tokyo-tech and JENDL FP Fission Yields Data File 2011(FPY- 2011). Tokyo-tech is newly created by Tsubakihara et al. at Tokyo Institute of Technology. FPY-2011 is currently the latest fission yield data in Japan. In the concerned nuclides, the relative difference (Tokyo-tech/FPY-2011 -1) in the production of Sb{sup 125} is 4.5% and that of Eu{sup 154} is -5.6%. The relative difference in the production of Sb{sup 125} is found to be caused by the difference in the independent yields of Sn{sup 125}, In{sup 125}, Cd{sup 125}, Ag{sup 125}, and Pd{sup 125}. The relative difference in Eu{sup 154} is found to be caused by the relative difference in the production of Sm{sup 152} and the relative difference in the cumulative yield of Eu{sup 153}.

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Radiogenic Side Effects After Hypofractionated Stereotactic Photon Radiotherapy of Choroidal Melanoma in 212 Patients Treated Between 1997 and 2007

Purpose: To evaluate side effects of hypofractionated stereotactic photon radiotherapy for patients with choroidal melanoma. Patients and Methods: Two hundred and twelve patients with choroidal melanoma unsuitable for ruthenium-106 brachytherapy or local resection were treated stereotactically at the Medical University of Vienna between 1997 and 2007 with a Linac with 6-MV photon beams in five fractions with 10, 12, or 14 Gy per fraction. Examinations for radiogenic side effects were performed at baseline and every 3 months in the first 2 years, then every 6 months until 5 years and then once a year thereafter until 10 years after radiotherapy. Adverse side effects were assessed using slit-lamp examination, funduscopy, gonioscopy, tonometry, and, if necessary, fundus photography and fluorescein angiography. Evaluations of incidence of side effects are based on an actuarial analysis. Results: One hundred and eighty-nine (89.2%) and 168 (79.2%) of the tumors were within 3 mm of the macula and the optic disc, respectively. The five most common radiotherapy side effects were retinopathy and optic neuropathy (114 cases and 107 cases, respectively), cataract development (87 cases), neovascular glaucoma (46 cases), and corneal epithelium defects (41 cases). In total, 33.6%, 38.5%, 51.2%, 75.5%, and 77.6% of the patients were free of any radiation retinopathy, optic neuropathy, cataract, neovascular glaucoma, or corneal epithelium defects 5 years after radiotherapy, respectively. Conclusion: In centrally located choroidal melanoma hypofractionated stereotactic photon radiotherapy shows a low to moderate rate of adverse long-term side effects comparable with those after proton beam radiotherapy. Future fractionation schemes should seek to further reduce adverse side effects rate while maintaining excellent local tumor control.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Plaque Brachytherapy for Uveal Melanoma: A Vision Prognostication Model

Purpose: To generate a vision prognostication model after plaque brachytherapy for uveal melanoma. Methods and Materials: All patients with primary single ciliary body or choroidal melanoma treated with iodine-125 or ruthenium-106 plaque brachytherapy between January 1, 2005, and June 30, 2010, were included. The primary endpoint was loss of visual acuity. Only patients with initial visual acuity better than or equal to 20/50 were used to evaluate visual acuity worse than 20/50 at the end of the study, and only patients with initial visual acuity better than or equal to 20/200 were used to evaluate visual acuity worse than 20/200 at the end of the study. Factors analyzed were sex, age, cataracts, diabetes, tumor size (basal dimension and apical height), tumor location, and radiation dose to the tumor apex, fovea, and optic disc. Univariate and multivariable Cox proportional hazards were used to determine the influence of baseline patient factors on vision loss. Kaplan-Meier curves (log rank analysis) were used to estimate freedom from vision loss. Results: Of 189 patients, 92% (174) were alive as of February 1, 2011. At presentation, visual acuity was better than or equal to 20/50 and better than or equal to 20/200 in 108 and 173 patients, respectively. Of these patients, 44.4% (48) had post-treatment visual acuity of worse than 20/50 and 25.4% (44) had post-treatment visual acuity worse than 20/200. By multivariable analysis, increased age (hazard ratio [HR] of 1.01 [1.00-1.03], P=.05), increase in tumor height (HR of 1.35 [1.22-1.48], P<.001), and a greater total dose to the fovea (HR of 1.01 [1.00-1.01], P<.001) were predictive of vision loss. This information was used to develop a nomogram predictive of vision loss. Conclusions: By providing a means to predict vision loss at 3 years after treatment, our vision prognostication model can be an important tool for patient selection and treatment counseling.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Fingerprints of Triaxiality in the Charge Radii of Neutron-Rich Ruthenium

We present the first measurements with a new collinear laser spectroscopy setup at the Argonne Tandem Linac Accelerator System, utilizing its unique capability to deliver neutron-rich refractory metal isotopes produced by the spontaneous fission of 252 Cf. We measured isotope shifts from optical spectra for nine radioactive ruthenium isotopes 106–114 Ru, reaching deep into the mid-shell region. The extracted charge radii are in excellent agreement with predictions from the Brussels-Skyrme-on-a-Grid models that account for the triaxial deformation of nuclear ground states. We show that triaxial deformation impacts charge radii in models that feature shell effects, in contrast to what could be concluded from a liquid drop analysis. This indicates that this exotic type of deformation should not be neglected in regions where it is known to occur, even if its presence cannot be unambiguously inferred through laser spectroscopy.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

AGR-1 Compact 4-1-1 Post-Irradiation Examination Results

Destructive post-irradiation examination was performed on AGR-1 fuel Compact 4-1-1, which was irradiated to a final compact-average burnup of 19.4% FIMA (fissions per initial metal atom) and a time-average, volume-average temperature of 1072°C. The analysis of this compact focused on characterizing the extent of fission product release from the particles and examining particles to determine the condition of the kernels and coating layers. The work included deconsolidation of the compact and leach-burn-leach analysis, visual inspection and gamma counting of individual particles, metallurgical preparation of selected particles, and examination of particle cross-sections with optical microscopy, electron microscopy, and elemental analysis. Deconsolidation-leach-burn-leach (DLBL) analysis revealed no particles with failed TRISO or failed SiC layers (as indicated by very low uranium inventory in all of the leach solutions). The total fractions of the predicted compact inventories of fission products Ce-144, Cs-134, Cs-137, and Sr-90 that were present in the compact outside of the SiC layers were <2×10 -6 , based on DLBL data. The Ag-110m fraction in the compact outside the SiC layers was 3.3×10 -2 , indicating appreciable release of silver through the intact coatings and subsequent retention in the OPyC layers or matrix. The Eu-154 fraction was 2.4×10 -4 , which is equivalent to the inventory in one average particle, and indicates a small but measurable level of release from the intact coatings. Gamma counting of 61 individual particles indicated no particles with anomalously low fission product retention. The average ratio of measured inventory to calculated inventory was close to a value of 1.0 for several fission product isotopes (Ce-144, Cs-134, and Cs-137), indicating good retention and reasonably good agreement with the predicted inventories. Measured-to-calculated (M/C) activity ratios for fission products Eu-154, Eu-155, Ru-106, Sb-125, and Zr-95 were significantly less than 1.0. However, as no significant release of these fission products from compacts was noted during previous analysis of the AGR-1 capsule components, the low M/C ratios are most likely an indication of a bias in the inventories predicted by physics simulations of the AGR-1 experiment. The distribution of Ag-110m M/C ratios was centered on a value of 1.02 and was fairly broad (standard deviation of 0.18, with values as high as 1.42 and as low as 0.68). Based on all data gathered to date, it is believed that silver retention in the particles was on average relatively high, but that the broad distribution in values among the particles represents significant variation in the inventory of Ag-110m generated in the particles. Ceramographic analysis of particle cross-sections revealed many of the characteristic microstructures often observed in irradiated AGR-1 particles from other fuel compacts. Palladium-rich fission product clusters were observed in the IPyC and SiC layers near the IPyC-SiC interface of three Compact 4-1-1 particle cross-sections. In spite of the presence of fission product clusters in the SiC layer, no significant corrosion or degradation of the layer was observed in any of the particles examined.

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Improvements in iodine and ruthenium removal from advanced liquid processing system

SRNL has considerable experience in designing, engineering, and operating systems for removing iodine-129 (I-129) and ruthenium-106 (Ru-106) from waste streams that are directly analogous to the Advanced Liquid Processing System (ALPS) waste streams. SRNL proposes to provide the technical background and design and engineering support for an improved I-129 and Ru-106 removal system for application to ALPS on the Fukushima Daiichi Nuclear Power Station (NPS).

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗